comparemela.com

BioPorto (NASDAQ COPENHAG:BIOPOR) A/S has announced that the strong performance of its flagship NGAL test drove revenue growth for the group in the first...

Related Keywords

Denmark ,Danish , ,Drug Administration ,Acute Kidney Injury ,Breakthrough Device ,Tony Pare ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.